Sector: MedicalSNTA (NASDAQ: SNTA)
Headlines
- Trading Overview for Sinobiopharma Inc. Issued by StockPreacher.com
Nov 19, 2009 06:52 AM | GSK, PBH, SNSS, SNTA
- Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090
Nov 18, 2009 08:02 AM | SNTA
- Synta Presents New Data on Mechanism of Action of Elesclomol at AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics
Nov 18, 2009 08:01 AM | SNTA
- Synta Pharmaceuticals to Present at the Lazard Capital Markets Annual Healthcare Conference
Nov 11, 2009 08:30 AM | SNTA
- Synta Pharmaceuticals Announces Updated Elesclomol SYMMETRYSM Data Presented at Melanoma XIII
Oct 12, 2009 08:01 AM | SNTA
- Griffin Securities Announces Investment Opinion on Targeting Cancer Stem Cells
Oct 09, 2009 09:11 AM | BMY, CRIS, EXEL, INFI, KERX
- Synta Pharmaceuticals Initiates Fourth Trial of STA-9090, a Novel Synthetic Small Molecule Hsp90 Inhibitor
Sep 29, 2009 08:01 AM | SNTA
- Synta Pharmaceuticals to Present at the R.W. Baird Healthcare Conference
Sep 03, 2009 07:30 AM | SNTA
- Synta Pharma Proceeds with Clinical Trial
Mar 17, 2009 12:41 PM | BMS, BMY, GSK, INFI, RHHBY, SNTA
- Research Note on Synta Pharma (SNTA)
Mar 13, 2009 07:58 PM | BMS, BMY, GSK, RHHBY, SNTA
- Synta Pharmaceuticals Reports Third Quarter 2009 Financial Results
Nov 04, 2009 07:51 AM | SNTA
- Synta Pharmaceuticals Reports Second Quarter 2009 Financial Results
Aug 04, 2009 07:51 AM | SNTA
- Synta Pharmaceuticals to Host Second-Quarter 2009 Conference Call on August 4, 2009
Jul 23, 2009 08:39 AM | SNTA
- Synta Pharmaceuticals Names Vojo Vukovic, M.D., Ph.D. Senior Vice President and Chief Medical Officer
Jun 19, 2009 10:01 AM | SNTA
- Synta and GSK End Elesclomol Collaboration Agreement
Jun 15, 2009 07:11 AM | SNTA
- Synta Pharmaceuticals Announces Presentation of Preliminary Results of Phase 3 SYMMETRY Trial of Elesclomol in Metastatic Melanoma at ASCO 2009
May 30, 2009 08:01 AM | SNTA
- Synta Announces Elesclomol Phase 3 Melanoma Data to be Featured in Oral Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
May 14, 2009 08:33 AM | SNTA
- Synta Pharmaceuticals to Present at the Deutsche Bank Health Care Conference
May 11, 2009 09:34 AM | SNTA
- Synta Pharmaceuticals Reports First Quarter 2009 Financial Results
May 07, 2009 07:22 AM | SNTA
- Synta Pharmaceuticals to Host First-Quarter 2009 Conference Call on May 7, 2009
Apr 23, 2009 08:38 AM | SNTA
- Form 4 SYNTA PHARMACEUTICALS For: Aug 24 Filed by: Koya Keizo (10K)
Aug 26, 2009 12:07 PM
- Form 4 SYNTA PHARMACEUTICALS For: Aug 06 Filed by: Chen Lin Huey (10K)
Aug 07, 2009 04:16 PM
- Form 4 SYNTA PHARMACEUTICALS For: Aug 06 Filed by: Chen Lan Bo (10K)
Aug 07, 2009 04:15 PM
- Form 4 SYNTA PHARMACEUTICALS For: Aug 06 Filed by: Bahcall Safi R (10K)
Aug 07, 2009 04:12 PM
- Form 3 SYNTA PHARMACEUTICALS For: Jul 13 Filed by: Vukovic Vojo (10K)
Jul 13, 2009 08:46 AM
- Form 4 SYNTA PHARMACEUTICALS For: Apr 13 Filed by: Rieder Wendy E (10K)
Apr 14, 2009 06:25 PM
- Form 4 SYNTA PHARMACEUTICALS For: Apr 13 Filed by: Ehrlich Keith S (10K)
Apr 14, 2009 06:20 PM
- Form 4 SYNTA PHARMACEUTICALS For: Apr 13 Filed by: Koya Keizo (10K)
Apr 14, 2009 06:18 PM
- Form 4 SYNTA PHARMACEUTICALS For: Apr 13 Filed by: Jacobson Eric W (10K)
Apr 14, 2009 06:18 PM
- Form 4 SYNTA PHARMACEUTICALS For: Apr 13 Filed by: Chadwick Jeremy G (10K)
Apr 14, 2009 06:14 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
SNTA
|
Compare to S&P
|
| YTD |
-37.58 %
|
-48.34 %
|
| 4 Weeks |
29.49 %
|
28.09 %
|
| 12 Weeks |
28.62 %
|
21.26 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 1,492.00 %
|
|
EPS Growth in Last Year: 546.15 %
|
|
Sales Growth in Last Quarter: 3,834.97 %
|
|
Sales Growth in Last Quarter: 10,151.97 %
|
|
